Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

High retinol intake may worsen hair loss in alopecia areata.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Use good lighting, consistent positioning, and proper camera settings for effective hair disorder photos.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Hair loss may indicate higher risk of heart disease.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

People with acne have more CD4+ immune cells in their skin than healthy people.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

FOXN1 gene variants cause low T cells and immune issues from birth.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Overexpressing Tβ4 in goats' hair follicles increases cashmere production and hair follicle growth.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

HuR is essential for Treg function and preventing autoimmunity.

Baricitinib significantly regrows hair in severe alopecia areata patients.